Cross-national comparisons of adolescent mental health and suicidality in the Middle East: a cross-sectional secondary analysis of the global school-based student health survey
From emotion regulation to suicide-specific coping: a qualitative study of self-regulatory processes in suicidal crises
Big Five personality profiles, self-reported distress, and resilience resources among adults in Italy after the acute COVID-19 emergency: a cross-sectional cluster-analytic study
NeuroCon-AutismNet: a privacy-preserving multimodal framework toward autism screening via diffusion-regularized EEG biomarkers and empathy-aware multilingual dialogue
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
Nature Medicine, Published online: 24 July 2026; doi:10.1038/s41591-026-04496-2
In the LITMUS study, serum biomarkers outperformed imaging for identifying patients at risk of MASH, whereas elastography was superior for staging advanced fibrosis and cirrhosis.
Drug Candidate Combats Age-Related Muscle Loss
Researchers in Japan have identified a compound that could help muscles stay strong as we age. Preclinical results published today in Scientific Reports uncover a promising new approach to treat conditions causing muscle loss and may help people preserve independence and quality of life in their later years.
Skeletal muscle is essential for movement, accounting for approximately 40% of an adult’s total body weight. Yet it is also one of the first tissues to decline with age, progressively leading to weakness, scarring, fat accumulation, and loss of fast-twitch muscle fibers.
The study focused on hepatocyte growth factor (HGF), a molecule that plays a crucial role in activating the repair of muscle fibers. In healthy muscle, this molecule is present in the tissue surrounding muscle fibers. When the muscle is injured or stimulated through exercise, HGF is released and binds to c-met receptors on stem cells within the skeletal muscle, known as satellite cells. This activates the satellite cells and enables them to proliferate and differentiate to repair muscle fibers.
Aging can interfere with this process, making it a key driver of age-related muscle wasting. In an earlier study, the same team found that aging causes HGF to undergo nitration, a chemical modification that prevents it from binding to c-met receptors.
“HGF is not necessarily missing as we age,” said Ryuichi Tatsumi, PhD, professor at Kyushu University. “Rather, it can be chemically altered after it is made. That led us to wonder whether a compound with strong antioxidant capacity might protect HGF, either by preventing nitration or by compensating for the functional loss it causes.”
Tatsumi’s team then identified two compounds with strong antioxidant activity that could potentially interfere with HGF nitration: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS). Both belong to a drug class known as trisulfides that has been gaining attention in preclinical research for their protective and anti-inflammatory properties across a wide range of indications.
While both drugs were able to suppress HGF nitration, only LASSS restored its ability to bind to c-met receptors. In fact, the drug candidate more than doubled HGF’s binding affinity while simultaneously preventing nitration.
“This exceeded our expectations,” said Tatsumi. “We knew trisulfides had diverse biological functions, but we never expected that simply mixing HGF with LASSS would produce such a striking effect. What this tells us is that LASSS does more than simply neutralize reactive molecules. It may interact directly with HGF and induce a subtle structural change, creating an enhanced ‘Super HGF’ form that binds c-met more strongly and resists nitration.”
The researchers then tested these effects in a mouse model of muscle atrophy. Compared to untreated animals, mice receiving LASSS showed a significant reduction in HGF nitration. Although further preclinical studies are needed before this approach can be tested in humans, these early findings point toward a promising strategy to preserve the muscle’s natural regenerative capacity and support healthy aging.
The post Drug Candidate Combats Age-Related Muscle Loss appeared first on Inside Precision Medicine.
STAT+: White House offers its science blueprint: More AI, less life sciences
For 18 months, the Trump administration has been accused by science advocates of shredding a social contract between academic researchers and the federal government that made the United States the world’s most powerful engine of discovery. Now it’s proposing a way to rebuild American science.
Taking inspiration from “Science — The Endless Frontier,” a 1945 manifesto that became the blueprint for the rise of American research universities, Trump’s science adviser, Michael Kratsios, this week put forth his version of such a report. Called “Science: A New Golden Age” and drafted by the White House Office of Science and Technology Policy, it calls for shifting hundreds of billions of research dollars from universities to industry, primarily tech and artificial intelligence companies.
The report acknowledges problems scientists have long attempted to grapple with, but advocates and scientists expressed concern that the report’s espoused goal of improving science is being undermined by other administration actions, chiefly the grievances expressed by President Trump and his aides against immigration, universities, and programs that they deem as promoting diversity, equity, and inclusion.
RCT of Mantram Repetition Versus Health Education for Veterans With PTSD and Chronic Pain
Interventions: Behavioral: Mantram Repetition Program for PTSD + Pain; Behavioral: Health Education while Living with Pain
Sponsors: VA Office of Research and Development
Not yet recruiting
3-Dimensional Optical Scanning to Assess and Monitor Malnutrition in Eating Disorders (3D-ED) Study
Sponsors: University of California, San Francisco; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Denver Health and Hospital Authority; University of Hawaii
Not yet recruiting

